These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 7584514
1. AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors in human brain tissues. Sawutz DG, Krafte DS, Oleynek JJ, Ault B. J Recept Signal Transduct Res; 1995 Jul; 15(6):829-46. PubMed ID: 7584514 [Abstract] [Full Text] [Related]
2. Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography. Cha JH, Makowiec RL, Penney JB, Young AB. Mol Pharmacol; 1992 May; 41(5):832-8. PubMed ID: 1375315 [Abstract] [Full Text] [Related]
3. Autoradiographic characterization of the non-N-methyl-D-aspartate binding sites in human cerebellum using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione. Hatziefthimiou A, Mitsacos A, Kouvelas ED. J Neurosci Res; 1994 Feb 15; 37(3):392-7. PubMed ID: 7909852 [Abstract] [Full Text] [Related]
4. Magnesium prevents seizure-induced reduction in excitatory amino acid receptor (kainate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) binding in pregnant rat brain. Hallak M, Hotra JW, Custodio D, Kruger ML. Am J Obstet Gynecol; 2000 Oct 15; 183(4):793-8. PubMed ID: 11035315 [Abstract] [Full Text] [Related]
5. N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment. Massicotte G, Kessler M, Lynch G, Baudry M. Mol Pharmacol; 1990 Feb 15; 37(2):278-85. PubMed ID: 2154675 [Abstract] [Full Text] [Related]
7. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors. Cai SX, Huang JC, Espitia SA, Tran M, Ilyin VI, Hawkinson JE, Woodward RM, Weber E, Keana JF. J Med Chem; 1997 Oct 24; 40(22):3679-86. PubMed ID: 9357535 [Abstract] [Full Text] [Related]
8. Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease. Wagster MV, Hedreen JC, Peyser CE, Folstein SE, Ross CA. Exp Neurol; 1994 May 24; 127(1):70-5. PubMed ID: 7515353 [Abstract] [Full Text] [Related]
9. (2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors. Zhou LM, Gu ZQ, Costa AM, Yamada KA, Mansson PE, Giordano T, Skolnick P, Jones KA. J Pharmacol Exp Ther; 1997 Jan 24; 280(1):422-7. PubMed ID: 8996224 [Abstract] [Full Text] [Related]
11. Effects of thiol-reagents on [3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to rat telencephalic membranes. Terramani T, Kessler M, Lynch G, Baudry M. Mol Pharmacol; 1988 Aug 24; 34(2):117-23. PubMed ID: 2901029 [Abstract] [Full Text] [Related]
12. Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships. Bang-Andersen B, Lenz SM, Skjaerbaek N, Søby KK, Hansen HO, Ebert B, Bøgesø KP, Krogsgaard-Larsen P. J Med Chem; 1997 Aug 29; 40(18):2831-42. PubMed ID: 9288165 [Abstract] [Full Text] [Related]
13. Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells. Varney MA, Rao SP, Jachec C, Deal C, Hess SD, Daggett LP, Lin F, Johnson EC, Veliçelebi G. J Pharmacol Exp Ther; 1998 Apr 29; 285(1):358-70. PubMed ID: 9536032 [Abstract] [Full Text] [Related]
14. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology. Verdoorn TA, Dingledine R. Mol Pharmacol; 1988 Sep 29; 34(3):298-307. PubMed ID: 2901662 [Abstract] [Full Text] [Related]
15. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain. Foster AC, Kemp JA, Leeson PD, Grimwood S, Donald AE, Marshall GR, Priestley T, Smith JD, Carling RW. Mol Pharmacol; 1992 May 29; 41(5):914-22. PubMed ID: 1375317 [Abstract] [Full Text] [Related]
16. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Curras MC, Dingledine R. Mol Pharmacol; 1992 Mar 29; 41(3):520-6. PubMed ID: 1372086 [Abstract] [Full Text] [Related]
17. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity. Nielsen EO, Varming T, Mathiesen C, Jensen LH, Moller A, Gouliaev AH, Wätjen F, Drejer J. J Pharmacol Exp Ther; 1999 Jun 29; 289(3):1492-501. PubMed ID: 10336544 [Abstract] [Full Text] [Related]
18. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC, Guet T, Bobichon C, Moreau C, Curutchet P, Lambolez B, de Carvalho LP, Cordi A, Lepagnol JM. Mol Pharmacol; 1992 Feb 29; 41(2):337-45. PubMed ID: 1371583 [Abstract] [Full Text] [Related]
19. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Egebjerg J, Bettler B, Hermans-Borgmeyer I, Heinemann S. Nature; 1991 Jun 27; 351(6329):745-8. PubMed ID: 1648177 [Abstract] [Full Text] [Related]
20. A ligand binding study of the interactions of guanine nucleotides with non-NMDA receptors. Gorodinsky A, Paas Y, Teichberg VI. Neurochem Int; 1993 Sep 27; 23(3):285-91. PubMed ID: 7693111 [Abstract] [Full Text] [Related] Page: [Next] [New Search]